Embla Medical hf (OTCPK:OSSFF)
$ 5.175 0 (0%) Market Cap: 2.10 Bil Enterprise Value: 2.56 Bil PE Ratio: 31.89 PB Ratio: 2.86 GF Score: 81/100

Q1 2022 Ossur hf Earnings Call Transcript

Apr 26, 2022 / 07:00AM GMT
Release Date Price: $5.44 (-5.39%)
Operator

Ladies and gentlemen, welcome to the Ãssur First Quarter Results 2022. Today, I am pleased to present Sveinn Sölvason. (Operator Instructions)

Mr. Sölvason, please go ahead.

Sveinn Solvason;ssur hf.;President;CEO
Ã

&

Thank you very much. I would like to welcome you to the Ãssur investor conference call here for quarter 1. My name is Sveinn Sölvason, and I am the President and CEO. And with me here in the room is also Edda Lara, our Director of IR. We will begin by going through the highlights for the quarter and then go through our guidance for the year, and then we'll go to Q&A at the end.

Now sales amounted to $170 million in the first quarter, which corresponds to 6% organic growth. The quarter started out slow with COVID-19 impacting volumes and activity levels. However, there was a positive trend throughout the quarter, and our sales in EMEA and the main European markets were particularly strong, which was a very positive sign here in quarter 1. At the end of February, we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot